Fifth Third Bancorp Royalty Pharma PLC Transaction History
Fifth Third Bancorp
- $27.1 Billion
- Q4 2024
A detailed history of Fifth Third Bancorp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Fifth Third Bancorp holds 1,530 shares of RPRX stock, worth $48,118. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,530
Previous 533
187.05%
Holding current value
$48,118
Previous $15,000
160.0%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RPRX
# of Institutions
413Shares Held
281MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.29 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$724 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$445 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$383 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...